Advertisement

Inflammation

, Volume 37, Issue 3, pp 858–870 | Cite as

Angiotensin II-Derived Reactive Oxygen Species Promote Angiogenesis in Human Late Endothelial Progenitor Cells Through Heme Oxygenase-1 via ERK1/2 and AKT/PI3K Pathways

  • Jingting Mai
  • Qiong Qiu
  • Yong Qing Lin
  • Nian Sang Luo
  • Hai Feng Zhang
  • Zhu Zhi Wen
  • Jing Feng Wang
  • Chen YangXin
Article

Abstract

Angiotensin II (Ang II), the main component of renin-angiotensin system, could mediate pathogenic angiogenesis in cardiovascular disorders. Late endothelial progenitor cells (EPCs) possess potent self-renewal and angiogenic potency superior to early EPCs, but few study focused on the cross-talk between Ang II and late EPCs. We observed that Ang II could increase reactive oxygen species (ROS) and promote capillary formation in late EPCs. Ang II-derived ROS could also upregulate heme oxygenase-1 (HO-1) expression, and treating late EPCs with HO-1 small interfering RNA or heme oxygenase inhibitor (HO inhibitor) could inhibit Ang II-induced tube formation and increase ROS level and apoptosis rate. In addition, PD98059 and LY294002 pretreatment attenuated Ang II-induced HO-1 expression. Accordingly, Ang II-derived ROS could promote angiogenesis in late EPCs by inducing HO-1 expression via ERK1/2 and AKT/PI3K pathways, and we believe HO-1 might be a promising intervention target in EPCs due to its potent proangiogenic, antioxidant, and antiapoptosis potentials.

KEY WORDS

endothelial progenitor cells heme oxygenase-1 angiotensin II angiogenesis 

Notes

Acknowledgments

This study was supported by a grant from the National Natural Science Foundation of China (nos. 81100101 and 81270212), Yat-sen Scholarship for Young Scientist, and Young Teacher Support Project by Sun Yat-sen University for Chen Yangxin.

Supplementary material

10753_2013_9806_Fig7_ESM.jpg (47 kb)
Fig. SI

VEGFR-2 and p-NOS levels were investigated in early and late EPCs after exposure to Ang II. The qRT-PCR was used to examine mRNA expression of VEGFR-2 (A) and protein level was examined by flow cytometry (B). Protein levels of p-eNOS (Ser1177) were tested by western blot. Protein levels of p-eNOS were normalized to the housekeeping protein beta-tubulin (C). Three independent experiments were performed. qRT-PCR results are expressed as mean ± SEM and presented by percentage of the control group. *P < 0.05 compared to control group (JPEG 47 kb)

10753_2013_9806_MOESM1_ESM.tif (638 kb)
High-resolution image (TIFF 637 kb)
10753_2013_9806_Fig8_ESM.jpg (29 kb)
Fig. SII

PEG-SOD was an appropriate antioxidant for abolishing the ROS induced by Ang II in late EPCs. (A) Intracellular ROS was detected by means of an oxidation-sensitive fluorescent probe (DCFH-DA) used flow cytometry. Late EPCs were exposed to Ang II (100 nM) for 48 h with vehicle or PEG-SOD (50 U/ml), N-acetyl-l-cysteine (NAC; 10 mM) and apocynin (selective inhibitor of NADPH oxidase;100 μM) (n = 3). (B) Effects of NAC and PEG-SOD in the angiogenesis function were examined. Late EPCs were treated with vehicle or with NAC or PEG-SOD for 24 h (n = 3). Results are expressed as mean ± SEM and presented by percentage of the control group (JPEG 28 kb)

10753_2013_9806_MOESM2_ESM.tif (304 kb)
High-resolution image (TIFF 303 kb)
10753_2013_9806_Fig9_ESM.jpg (69 kb)
Fig. SIII

Ang II stimulated HO-1 expression in late EPCs. The qRT-PCR showed HO-1 mRNA levels for indicated concentrations (0.1, 1, 10, 100 nM) (A) and time (4, 12, 24 h) (B) under Ang II stimulation (n = 3). # P < 0.05 compared to control group; * P < 0.05 compared to Ang 100 nM 12 h group. Western blots showed HO-1 protein levels for indicated concentrations (1, 10 nM, 100 nM, 1,000 mM) (C) and time (12, 24, 36, and 48 h) (D) under Ang II stimulation (n = 3). Data were normalized to the housekeeping protein beta-tubulin # P < 0.05 compared to control group; * P < 0.05 compared to Ang 100 nM 24-h group. Results are expressed as mean ± SEM and presented by percentage of the control group. # P < 0.05 compared to control group (JPEG 69 kb)

10753_2013_9806_MOESM3_ESM.tif (1011 kb)
High-resolution image (TIFF 1,011 kb)
10753_2013_9806_Fig10_ESM.jpg (60 kb)
Fig. SIV

HO-1 siRNA transfection effectively suppress Ang II-induced HO-1 expression and HO-1 inducer CoPPIX could significantly upregulate HO-1 expression in late EPCs. (A) PE conjugated HO-1 siRNA were used to elevate the transfection efficiency by fluorescence microscopy. HO-1 mRNA (C) and protein (D) expression were evaluated. Late EPCs were exposed to Ang II (100 nM) in presence of HO-1 siRNA (100 nM) or mock siRNA (100 nM). Cells were also treated with CoPPIX (50 μmol/L) alone. Protein levels of HO-1 were normalized to the housekeeping protein beta-tubulin. Three independent experiments were performed. Results are expressed as mean ± SEM and presented by percentage of the control group. # P < 0.05 compared to control group. * P < 0.05 compared to Ang II group (JPEG 60 kb)

10753_2013_9806_MOESM4_ESM.tif (2 mb)
High-resolution image (TIFF 2,002 kb)
10753_2013_9806_Fig11_ESM.jpg (37 kb)
Fig. SV

Representative immunoblot showed p-ERK/ERK, p-AKT(Ser473)/AKT, p-p38/p38, p-JNK/JNK amounts of EPCs in response to Ang II for indicated time (0, 24, 48, and 72 h). VEGF was added to maintain the vitality of EPCs in every group, n = 3). Data were normalized to the housekeeping protein GAPDH. # P < 0.05 compared to control group (JPEG 37 kb)

10753_2013_9806_MOESM5_ESM.tif (978 kb)
High-resolution image (TIFF 977 kb)

References

  1. 1.
    Ferrario, C.M., and W.B. Strawn. 2006. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. American Journal of Cardiology 98: 121–128.PubMedCrossRefGoogle Scholar
  2. 2.
    Nicholls, M.G., A.M. Richards, and M. Agarwal. 1998. The importance of the renin-angiotensin system in cardiovascular disease. Journal of Human Hypertension 12: 295–299.PubMedCrossRefGoogle Scholar
  3. 3.
    Egami, K., T. Murohara, T. Shimada, K. Sasaki, S. Shintani, T. Sugaya, M. Ishii, T. Akagi, H. Ikeda, T. Matsuishi, and T. Imaizumi. 2003. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. Journal of Clinical Investigation 112: 67–75.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Suganuma, T., K. Ino, K. Shibata, H. Kajiyama, T. Nagasaka, S. Mizutani, and F. Kikkawa. 2005. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clinical Cancer Research 11: 2686–2694.PubMedCrossRefGoogle Scholar
  5. 5.
    Heffelfinger, S.C. 2007. The renin angiotensin system in the regulation of angiogenesis. Current Pharmaceutical Design 13: 1215–1229.PubMedCrossRefGoogle Scholar
  6. 6.
    Otani, A., H. Takagi, H. Oh, S. Koyama, and Y. Honda. 2001. Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells. Diabetes 50: 867–875.PubMedCrossRefGoogle Scholar
  7. 7.
    Sasaki, K., T. Murohara, H. Ikeda, T. Sugaya, T. Shimada, S. Shintani, and T. Imaizumi. 2002. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. Journal of Clinical Investigation 109: 603–611.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    De Giusti, V.C., C.D. Garciarena, and E.A. Aiello. 2009. Role of reactive oxygen species (ROS) in angiotensin II-induced stimulation of the cardiac Na+/HCO3- cotransport. Journal of Molecular and Cellular Cardiology 47: 716–722.PubMedCrossRefGoogle Scholar
  9. 9.
    Touyz, R.M. 2004. Reactive oxygen species and angiotensin II signaling in vascular cells—implications in cardiovascular disease. Brazilian Journal of Medical and Biological Research 37: 1263–1273.PubMedCrossRefGoogle Scholar
  10. 10.
    Feliers, D., Y. Gorin, G. Ghosh-Choudhury, H.E. Abboud, and B.S. Kasinath. 2006. Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species. American Journal of Physiology. Renal Physiology 290: F927–F936.PubMedCrossRefGoogle Scholar
  11. 11.
    Uemura, H., H. Ishiguro, Y. Ishiguro, K. Hoshino, S. Takahashi, and Y. Kubota. 2008. Angiotensin II induces oxidative stress in prostate cancer. Molecular Cancer Research 6: 250–258.PubMedCrossRefGoogle Scholar
  12. 12.
    Pelliccia, F., C. Cianfrocca, G. Rosano, G. Mercuro, G. Speciale, and V. Pasceri. 2010. Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study. JACC. Cardiovascular Interventions 3: 78–86.PubMedCrossRefGoogle Scholar
  13. 13.
    Hirschi, K.K., D.A. Ingram, and M.C. Yoder. 2008. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology 28: 1584–1595.PubMedCrossRefGoogle Scholar
  14. 14.
    Ribatti, D. 2004. The involvement of endothelial progenitor cells in tumor angiogenesis. Journal of Cellular and Molecular Medicine 8: 294–300.PubMedCrossRefGoogle Scholar
  15. 15.
    Gao, D., D.J. Nolan, A.S. Mellick, K. Bambino, K. McDonnell, and V. Mittal. 2008. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319: 195–198.PubMedCrossRefGoogle Scholar
  16. 16.
    Rehman, J., J. Li, C.M. Orschell, and K.L. March. 2003. Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164–1169.PubMedCrossRefGoogle Scholar
  17. 17.
    Hur, J., C.H. Yoon, H.S. Kim, J.H. Choi, H.J. Kang, K.K. Hwang, B.H. Oh, M.M. Lee, and Y.B. Park. 2004. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 24: 288–293.PubMedCrossRefGoogle Scholar
  18. 18.
    Endtmann, C., T. Ebrahimian, T. Czech, O. Arfa, U. Laufs, M. Fritz, K. Wassmann, N. Werner, V. Petoumenos, G. Nickenig, and S. Wassmann. 2011. Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration. Hypertension 58: 394–403.PubMedCrossRefGoogle Scholar
  19. 19.
    Imanishi, T., T. Hano, and I. Nishio. 2004. Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. Hypertension Research 27: 101–108.PubMedCrossRefGoogle Scholar
  20. 20.
    Sanada, F., Y. Taniyama, J. Azuma, K. Iekushi, N. Dosaka, T. Yokoi, N. Koibuchi, H. Kusunoki, Y. Aizawa, and R. Morishita. 2009. Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence. Hypertension 53: 77–82.PubMedCrossRefGoogle Scholar
  21. 21.
    Roks, A.J., and I.I. Angiotensin. 2011. Deteriorates endothelial progenitor cells: good intentions with bad consequences. Hypertension 58: 356–358.PubMedCrossRefGoogle Scholar
  22. 22.
    Yin, T., X. Ma, L. Zhao, K. Cheng, and H. Wang. 2008. Angiotensin II promotes NO production, inhibits apoptosis and enhances adhesion potential of bone marrow-derived endothelial progenitor cells. Cell Research 18: 792–799.PubMedCrossRefGoogle Scholar
  23. 23.
    Aizawa, T., N. Ishizaka, J. Taguchi, R. Nagai, I. Mori, S.S. Tang, J.R. Ingelfinger, and M. Ohno. 2000. Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension 35: 800–806.PubMedCrossRefGoogle Scholar
  24. 24.
    Dulak, J., J. Deshane, A. Jozkowicz, and A. Agarwal. 2008. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 117: 231–241.PubMedCrossRefGoogle Scholar
  25. 25.
    Sunamura, M., D.G. Duda, M.H. Ghattas, L. Lozonschi, F. Motoi, J. Yamauchi, S. Matsuno, S. Shibahara, and N.G. Abraham. 2003. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 6: 15–24.PubMedCrossRefGoogle Scholar
  26. 26.
    Deshane, J., S. Chen, S. Caballero, A. Grochot-Przeczek, H. Was, C.S. Li, R. Lach, T.D. Hock, B. Chen, N. Hill-Kapturczak, G.P. Siegal, J. Dulak, A. Jozkowicz, M.B. Grant, and A. Agarwal. 2007. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. Journal of Experimental Medicine 204: 605–618.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Berberat, P.O., Z. Dambrauskas, A. Gulbinas, T. Giese, N. Giese, B. Kunzli, F. Autschbach, S. Meuer, M.W. Buchler, and H. Friess. 2005. Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clinical Cancer Research 11: 3790–3798.PubMedCrossRefGoogle Scholar
  28. 28.
    Hanna, I.R., Y. Taniyama, K. Szocs, P. Rocic, and K.K. Griendling. 2002. NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxidants and Redox Signaling 4: 899–914.PubMedCrossRefGoogle Scholar
  29. 29.
    Imanishi, T., T. Hano, and I. Nishio. 2005. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. Journal of Hypertension 23: 97–104.PubMedCrossRefGoogle Scholar
  30. 30.
    Dandapat, A., C. Hu, L. Sun, and J.L. Mehta. 2007. Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 27: 2435–2442.PubMedCrossRefGoogle Scholar
  31. 31.
    Ushio-Fukai, M. 2006. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovascular Research 71: 226–235.PubMedCrossRefGoogle Scholar
  32. 32.
    Circu, M.L., and T.Y. Aw. 2010. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radical Biology and Medicine 48: 749–762.PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Wu, B.J., R.G. Midwinter, C. Cassano, K. Beck, Y. Wang, D. Changsiri, J.R. Gamble, and R. Stocker. 2009. Heme oxygenase-1 increases endothelial progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology 29: 1537–1542.PubMedCrossRefGoogle Scholar
  34. 34.
    Lin, H.H., Y.H. Chen, S.F. Yet, and L.Y. Chau. 2009. After vascular injury, heme oxygenase-1/carbon monoxide enhances re-endothelialization via promoting mobilization of circulating endothelial progenitor cells. Journal of Thrombosis and Haemostasis 7: 1401–1408.PubMedCrossRefGoogle Scholar
  35. 35.
    Hur, J., C.H. Yoon, C.S. Lee, T.Y. Kim, I.Y. Oh, K.W. Park, J.H. Kim, H.S. Lee, H.J. Kang, I.H. Chae, B.H. Oh, Y.B. Park, and H.S. Kim. 2007. Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle. Stem Cells 25: 1769–1778.PubMedCrossRefGoogle Scholar
  36. 36.
    Friedrich, E.B., C. Werner, K. Walenta, M. Bohm, and B. Scheller. 2009. Role of extracellular signal-regulated kinase for endothelial progenitor cell dysfunction in coronary artery disease. Basic Research in Cardiology 104: 613–620.PubMedCrossRefGoogle Scholar
  37. 37.
    Wang, J.Y., Y.T. Lee, P.F. Chang, and L.Y. Chau. 2009. Hemin promotes proliferation and differentiation of endothelial progenitor cells via activation of AKT and ERK. Journal of Cellular Physiology 219: 617–625.PubMedCrossRefGoogle Scholar
  38. 38.
    Khurana, R., M. Simons, J.F. Martin, and I.C. Zachary. 2005. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 112: 1813–1824.PubMedCrossRefGoogle Scholar
  39. 39.
    Virmani, R., F.D. Kolodgie, A.P. Burke, A.V. Finn, H.K. Gold, T.N. Tulenko, S.P. Wrenn, and J. Narula. 2005. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arteriosclerosis, Thrombosis, and Vascular Biology 25: 2054–2061.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Jingting Mai
    • 1
    • 2
  • Qiong Qiu
    • 1
    • 2
  • Yong Qing Lin
    • 1
    • 2
  • Nian Sang Luo
    • 1
    • 2
  • Hai Feng Zhang
    • 1
    • 2
  • Zhu Zhi Wen
    • 1
    • 2
  • Jing Feng Wang
    • 1
    • 2
  • Chen YangXin
    • 1
    • 2
  1. 1.Department of CardiologySun Yat-sen Memorial Hospital of Sun Yat-sen UniversityGuangzhouChina
  2. 2.Guangdong Province Key Laboratory of Arrhythmia and ElectrophysiologyGuangzhouChina

Personalised recommendations